GCP inspection

The sponsor has submitted an MAA dossier to EMA for our product, BP02-Dazublys. During the process, a GCP inspection EMA/IN/0000173500 was announced for two investigator sites and the sponsor (CuraTeQ Bio) site in Hyderabad. However, as a sponsor, we are unable to find this request among the sites chosen for these inspections. We kindly request your assistance in resolving this issue as soon as possible.

The issue has now been addressed as part of the GCP procedure mentioned. Please note that Forum posts are intended for questions on general issues and applicants' discussions, and that no confidential information should be disclosed.
The Forum does not replace the existing communication channels:

• Questions on ongoing procedures at EMA should be submitted as a reply to any email received from IRIS regarding the specific case.
• Use this form to send a request for information from the European Medicines Agency or to make a formal request for access to EMA documents that are not already published on the EMA website. 
• Problems and technical issues about IRIS should be reported to the EMA ServiceNow. If you have difficulties in obtaining a role or affiliation to access IRIS, please select "IRIS account access and management" as the service, in the specific ServiceNow page.